Skip to main content
Premium Trial:

Request an Annual Quote

Dawn Berry

Dawn Berry has become president of Luna DNA, a genomic and medical research database powered by the blockchain and owned by its community. Previously, she was vice president of applied genomics at Illumina, which she joined in 2005 as a market development specialist. Prior to that, she was with Genaissance Pharmaceuticals, promoting clinical genetics testing services for pharmaceutical trials. Berry holds a BS in biology from the University of Vermont and an MBA from the University of Connecticut School of Business.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.